1. Home
  2. BRN vs LSTA Comparison

BRN vs LSTA Comparison

Compare BRN & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barnwell Industries Inc.

BRN

Barnwell Industries Inc.

N/A

Current Price

$0.87

Market Cap

13.7M

Sector

Energy

ML Signal

N/A

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

BUY

Current Price

$1.00

Market Cap

15.9M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BRN
LSTA
Founded
1956
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Misc Health and Biotechnology Services
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7M
15.9M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
BRN
LSTA
Price
$0.87
$1.00
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 98.4K
78.9K
Earning Date
08-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.42
EPS
★ N/A
N/A
Revenue
$13,697,000.00
★ $35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 56.90
52 Week Low
$0.84
$0.96
52 Week High
$1.40
$5.07

Technical Indicators

Market Signals
Indicator
BRN
LSTA
Relative Strength Index (RSI) 40.09 34.39
Support Level $0.84 $0.99
Resistance Level $1.11 $1.28
Average True Range (ATR) 0.06 0.10
MACD -0.00 -0.00
Stochastic Oscillator 22.31 11.02

Price Performance

Historical Comparison
BRN
LSTA

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: